Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppina De Simone

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
Chemical Communications (Cambridge, England)|October 11, 2016
Benzoxaborole as a new chemotype for carbonic anhydrase inhibitionVincenzo Alterio, Roberta Cadoni, Davide Esposito, et al.
Journal of Medicinal Chemistry|April 29, 2017
Probing Molecular Interactions between Human Carbonic Anhydrases (hCAs) and a Novel Class of BenzenesulfonamidesElvira Bruno, Maria Rosa Buemi, Anna Di Fiore, et al.
European Journal of Medicinal Chemistry|September 7, 2023
Discovery of a novel series of potent carbonic anhydrase inhibitors with selective affinity for μ Opioid receptor for Safer and long-lasting analgesiaAndrea Angeli, Laura Micheli, Rita Turnaturi, et al.
European Journal of Medicinal Chemistry|December 12, 2018
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moietyMaria Rosa Buemi, Anna Di Fiore, Laura De Luca, et al.
Journal of Medicinal Chemistry|April 29, 2026
Discovery of a Mixed and Prodrug-Like Inhibition Mechanism for Phosphocoumarins and Phosphoquinolinones against Human Carbonic AnhydrasesAlessio Nocentini, Simone Giovannuzzi, Vincenzo Alterio, et al.
Journal of Medicinal Chemistry|October 27, 2015
Discovery of 1,1'-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV InhibitorsGiuseppe La Regina, Antonio Coluccia, Valeria Famiglini, et al.
Frontiers in Public Health|September 4, 2023
Clinical outcomes of a digitally supported approach for self-management of type 2 diabetes mellitusVincenzo De Luca, Lutgarda Bozzetto, Clemente Giglio, et al.
Metabolites|October 17, 2020
Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor MicroenvironmentAndrea Angeli, Fabrizio Carta, Alessio Nocentini, et al.
Molecular Cancer Therapeutics|August 30, 2008
Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallographyL W Lawrence Woo, Delphine S Fischer, Christopher M Sharland, et al.
Journal of Proteome Research|November 28, 2012
Characterization of carbonic anhydrase IX interactome reveals proteins assisting its nuclear localization in hypoxic cellsPasquale Buanne, Giovanni Renzone, Francesca Monteleone, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Chemical Communications (Cambridge, England)|October 11, 2016
Benzoxaborole as a new chemotype for carbonic anhydrase inhibitionVincenzo Alterio, Roberta Cadoni, Davide Esposito, et al.
Journal of Medicinal Chemistry|April 29, 2017
Probing Molecular Interactions between Human Carbonic Anhydrases (hCAs) and a Novel Class of BenzenesulfonamidesElvira Bruno, Maria Rosa Buemi, Anna Di Fiore, et al.
European Journal of Medicinal Chemistry|September 7, 2023
Discovery of a novel series of potent carbonic anhydrase inhibitors with selective affinity for μ Opioid receptor for Safer and long-lasting analgesiaAndrea Angeli, Laura Micheli, Rita Turnaturi, et al.
European Journal of Medicinal Chemistry|December 12, 2018
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moietyMaria Rosa Buemi, Anna Di Fiore, Laura De Luca, et al.
Journal of Medicinal Chemistry|April 29, 2026
Discovery of a Mixed and Prodrug-Like Inhibition Mechanism for Phosphocoumarins and Phosphoquinolinones against Human Carbonic AnhydrasesAlessio Nocentini, Simone Giovannuzzi, Vincenzo Alterio, et al.
Journal of Medicinal Chemistry|October 27, 2015
Discovery of 1,1'-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV InhibitorsGiuseppe La Regina, Antonio Coluccia, Valeria Famiglini, et al.
Frontiers in Public Health|September 4, 2023
Clinical outcomes of a digitally supported approach for self-management of type 2 diabetes mellitusVincenzo De Luca, Lutgarda Bozzetto, Clemente Giglio, et al.
Metabolites|October 17, 2020
Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor MicroenvironmentAndrea Angeli, Fabrizio Carta, Alessio Nocentini, et al.
Molecular Cancer Therapeutics|August 30, 2008
Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallographyL W Lawrence Woo, Delphine S Fischer, Christopher M Sharland, et al.
Journal of Proteome Research|November 28, 2012
Characterization of carbonic anhydrase IX interactome reveals proteins assisting its nuclear localization in hypoxic cellsPasquale Buanne, Giovanni Renzone, Francesca Monteleone, et al.
Pageof 15